about
Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's diseaseDysregulation of glutathione homeostasis in neurodegenerative diseasesAmyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's diseaseLocalized AL amyloidosis: a suicidal neoplasm?Tau physiology and pathomechanisms in frontotemporal lobar degenerationInhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiolNanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer's-Associated Aβ Oligomers.Geniposide Protects Primary Cortical Neurons against Oligomeric Aβ1-42-Induced Neurotoxicity through a Mitochondrial PathwayTimosaponin-BII inhibits the up-regulation of BACE1 induced by ferric chloride in rat retinaCell therapy: a safe and efficacious therapeutic treatment for Alzheimer's disease in APP+PS1 miceNeuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.Unfolded protein response-induced ERdj3 secretion links ER stress to extracellular proteostasis.ENU mutagenesis screen to establish motor phenotypes in wild-type mice and modifiers of a pre-existing motor phenotype in tau mutant mice.New insights in the amyloid-Beta interaction with mitochondriaSex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau proteinSmall-molecule BACE1 inhibitors: a patent literature review (2006 - 2011).Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer's disease pathogenesis.Targeting synaptic dysfunction in Alzheimer's disease therapy.Decoding the non-coding RNAs in Alzheimer's disease.Barcoding heat shock proteins to human diseases: looking beyond the heat shock responseClearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer's DiseaseApigenin modulates the expression levels of pro-inflammatory mediators to reduce the human insulin amyloid-induced oxidant damages in SK-N-MC cells.Alzheimer's disease and epilepsy: insight from animal models.Evidence against a role of P-glycoprotein in the clearance of the Alzheimer's disease Aβ1-42 peptidesOxidative damage and amyloid-β metabolism in brain regions of the longest-lived rodents.Studying the Progression of Amyloid Pathology and Its Therapy Using Translational Longitudinal Model of Accumulation and Distribution of Amyloid Beta.Novel analogs of allopregnanolone show improved efficiency and specificity in neuroprotection and stimulation of proliferation.Tau45-230 association with the cytoskeleton and membrane-bound organelles: Functional implications in neurodegeneration.Inhibition of the Aggregation and Toxicity of the Minimal Amyloidogenic Fragment of Tau by Its Pro-Substituted Analogues.Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study.
P2860
Q26781090-658D6772-D7AA-422D-AD30-DDD8A6704306Q26822726-ABF9ABAA-86B1-43C7-BDBB-73A1D0C2FF0AQ27012950-22634392-D051-481A-935E-347A82040CB9Q27692643-BB9C6598-26B0-4CAA-9677-363C768C8C17Q28070250-843137A0-6104-4D73-B171-5A9BDB5B5D69Q28478362-4B16D715-B7FB-4426-BB83-BFB599656011Q28546877-041C862B-43F3-41CB-A08B-5BA840D42DC5Q28551172-666D9B09-AB36-4A07-9139-317CD1A74767Q34452606-79C32422-1601-4548-BA43-50EFBEDBAAFAQ34506405-A4DA90BE-3F15-43D8-A901-6CA3A595A211Q34656208-C5FCF1E6-A716-45D0-B028-98CA5779489DQ34923990-BB00A820-BF1E-4FE2-8040-CADB7685941BQ35636403-4BC657D2-EB1D-4CFE-B1AE-8ADD86DCDC2AQ35864854-940EDD92-6CC3-4CB9-B256-DAAE22E89A22Q36426980-2B3BB51A-FC4F-471B-A33D-667C20A720B4Q38003497-5CD3C2FC-7892-45FE-AD16-99083F253476Q38014755-BF7CAA44-F74A-4722-9A9D-9EBEDC2F72C7Q38036916-347B5D12-3D3A-4040-A901-EA544660E5A7Q38041425-991F0458-ED62-4ABA-9B6C-01E3019AFC7EQ38203487-F6A5A1C6-0646-4464-8DC3-61A5AAF6078AQ38269095-68DC6F2B-3E09-41D5-99AB-03ED6EE6ABB4Q38734570-2801D73F-D4FF-4E9F-B4D9-DC34E73B68B4Q38948962-C1512077-80FC-4916-94EA-5D834E17B661Q39598179-E34DD80C-FD5D-44AF-8569-56E5AD230C73Q39885064-C868C19C-6AD8-4D4A-84C9-1726F71B888FQ40397640-C3003A1F-9706-4784-A879-DCCC3EBA74D3Q42621653-BEAEC0FD-C462-498A-90E8-29082F9C11BAQ47424155-36FDB7D4-2C5A-46E2-A9EA-BE77A81DB4CBQ47900700-2921E337-6A39-4637-9E31-65D7DA3488B8Q50863156-8B924E19-D12A-4080-B937-957540DEAA8CQ53398026-0F21CC5F-7816-420F-B6FA-C31FD7192445
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Modes of Aβ toxicity in Alzheimer's disease.
@ast
Modes of Aβ toxicity in Alzheimer's disease.
@en
type
label
Modes of Aβ toxicity in Alzheimer's disease.
@ast
Modes of Aβ toxicity in Alzheimer's disease.
@en
prefLabel
Modes of Aβ toxicity in Alzheimer's disease.
@ast
Modes of Aβ toxicity in Alzheimer's disease.
@en
P2860
P50
P921
P1476
Modes of Aβ toxicity in Alzheimer's disease.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00018-011-0750-2
P577
2011-06-25T00:00:00Z
2011-10-01T00:00:00Z